NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









OncoTartis, Inc.

OncoTartis, Inc.

Private
Orchard Park, New YorkHealthcare & Life Scienceshttps://www.refreshandhealth.com/contact

Last Round

Series B

Dec 11, 2017

Total Funding Raised

$9.47M

Company Overview

OncoTartis, Inc. is a biotechnology company that develops a novel category of anti-cancer drugs directed against tissue-specific targets for a variety of malignancies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoveryoncologysmall-molecule inhibitornicotinamide phosphoribosyltransferase inhibitorNAMPT inhibitorclinical trialsprecision medicinehematological malignanciesbiotech startupcancer therapeuticsdrug pipelinebiopharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OncoTartis, Inc. Comps

Public and private peers based on sector, stage, and business model.

OncoTartis, Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

OncoTartis, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BDec 11, 2017
GrantDec 28, 2011
Series AFeb 17, 2011

OncoTartis, Inc. Investors

Notable investors and investment history

OncoTartis, Inc. investors
InvestorRounds
Skolkovo FoundationGrant
Pharmstandard International S.A.Series B

OncoTartis, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OncoTartis, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OncoTartis, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersOrchard Park, New York
Employee Range1
Year Founded2010
Last FundingDec 11, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.